Filter
713
Filtered Results: 713
Text search:
pharmaceutical
quality
control
laboratories
Featured
Recommendations
77
New Publications
216
Language
Document type
No document type
360
Studies & Reports
135
Guidelines
113
Strategic & Response Plan
51
Manuals
37
Training Material
7
Situation Updates
6
Fact sheets
3
Resource Platforms
1
Countries / Regions
India
43
Kenya
33
Ethiopia
29
Nigeria
19
Western and Central Europe
17
South Africa
17
Ghana
15
Sierra Leone
15
Uganda
15
Nepal
13
Global
13
Bangladesh
13
Liberia
13
Malawi
12
Tanzania
12
Philippines
11
Africa
10
Eastern Europe
10
Rwanda
9
Cambodia
9
Zambia
9
Namibia
8
Ukraine
7
Senegal
6
Burkina Faso
6
Zimbabwe
6
Latin America and the Carribbean
6
South–East Asia Region
6
Myanmar / Burma
6
Syria
5
Eswatini/ Swaziland
5
Thailand
4
Lesotho
4
Benin
4
Haiti
4
Botswana
4
Indonesia
4
Cameroon
3
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Vietnam
3
Pakistan
3
Albania
2
Laos
2
Guinea
2
USA
2
Asia
2
Venezuela
2
Western Pacific Region
2
Madagascar
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Peru
1
Mozambique
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
Gabon
1
Turkmenistan
1
France
1
Maldives
1
Papua New Guinea
1
Moldova
1
Sudan
1
Yemen
1
Mali
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
340
Clinical Guidelines
36
Key Resources
35
Public Health
21
Pharmacy & Technologies
21
Women & Child Health
13
Capacity Building
3
Toolboxes
AMR
123
COVID-19
54
Pharmacy
54
TB
46
Rapid Response
36
NTDs
22
HIV
18
Mental Health
16
Malaria
13
Planetary Health
11
Conflict
10
Health Financing Toolbox
9
Caregiver
8
Polio
8
Ebola & Marburg
6
Global Health Education
6
Specific Hazards
5
Natural Hazards
4
NCDs
4
Refugee
3
Cholera
3
Zika
2
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm...
5th edition.
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
